Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-20

FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr.Reddys Laboratories Inc)

View source ↗

Summary

FDA approved a supplemental application for ARIPIPRAZOLE by Dr. Reddy's Laboratories Inc. under the ANDA, authorizing a modification to the approved generic pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

SUPPL AP for ARIPIPRAZOLE (ARIPIPRAZOLE)